TY - JOUR
T1 - The spectrum of intermediate SCN8A-related epilepsy
AU - Johannesen, Katrine M.
AU - Gardella, Elena
AU - Encinas, Alejandra C.
AU - Lehesjoki, Anna Elina
AU - Linnankivi, Tarja
AU - Petersen, Michael B.
AU - Lund, Ida Charlotte Bay
AU - Blichfeldt, Susanne
AU - Miranda, Maria J.
AU - Pal, Deb K.
AU - Lascelles, Karine
AU - Procopis, Peter
AU - Orsini, Alessandro
AU - Bonuccelli, Alice
AU - Giacomini, Thea
AU - Helbig, Ingo
AU - Fenger, Christina D.
AU - Sisodiya, Sanjay M.
AU - Hernandez-Hernandez, Laura
AU - Krithika, Sundararaman
AU - Rumple, Melissa
AU - Masnada, Silvia
AU - Valente, Marialuisa
AU - Cereda, Cristina
AU - Giordano, Lucio
AU - Accorsi, Patrizia
AU - Bürki, Sarah E.
AU - Mancardi, Margherita
AU - Korff, Christian
AU - Guerrini, Renzo
AU - von Spiczak, Sarah
AU - Hoffman-Zacharska, Dorota
AU - Mazurczak, Tomasz
AU - Coppola, Antonietta
AU - Buono, Salvatore
AU - Vecchi, Marilena
AU - Hammer, Michael F.
AU - Varesio, Costanza
AU - Veggiotti, Pierangelo
AU - Lal, Dennis
AU - Brünger, Tobias
AU - Zara, Federico
AU - Striano, Pasquale
AU - Rubboli, Guido
AU - Møller, Rikke S.
N1 - Publisher Copyright:
Wiley Periodicals, Inc. © 2019 International League Against Epilepsy
PY - 2019/5
Y1 - 2019/5
N2 - Objective: Pathogenic variants in SCN8A have been associated with a wide spectrum of epilepsy phenotypes, ranging from benign familial infantile seizures (BFIS) to epileptic encephalopathies with variable severity. Furthermore, a few patients with intellectual disability (ID) or movement disorders without epilepsy have been reported. The vast majority of the published SCN8A patients suffer from severe developmental and epileptic encephalopathy (DEE). In this study, we aimed to provide further insight on the spectrum of milder SCN8A-related epilepsies. Methods: A cohort of 1095 patients were screened using a next generation sequencing panel. Further patients were ascertained from a network of epilepsy genetics clinics. Patients with severe DEE and BFIS were excluded from the study. Results: We found 36 probands who presented with an SCN8A-related epilepsy and normal intellect (33%) or mild (61%) to moderate ID (6%). All patients presented with epilepsy between age 1.5 months and 7 years (mean = 13.6 months), and 58% of these became seizure-free, two-thirds on monotherapy. Neurological disturbances included ataxia (28%) and hypotonia (19%) as the most prominent features. Interictal electroencephalogram was normal in 41%. Several recurrent variants were observed, including Ile763Val, Val891Met, Gly1475Arg, Gly1483Lys, Phe1588Leu, Arg1617Gln, Ala1650Val/Thr, Arg1872Gln, and Asn1877Ser. Significance: With this study, we explore the electroclinical features of an intermediate SCN8A-related epilepsy with mild cognitive impairment, which is for the majority a treatable epilepsy.
AB - Objective: Pathogenic variants in SCN8A have been associated with a wide spectrum of epilepsy phenotypes, ranging from benign familial infantile seizures (BFIS) to epileptic encephalopathies with variable severity. Furthermore, a few patients with intellectual disability (ID) or movement disorders without epilepsy have been reported. The vast majority of the published SCN8A patients suffer from severe developmental and epileptic encephalopathy (DEE). In this study, we aimed to provide further insight on the spectrum of milder SCN8A-related epilepsies. Methods: A cohort of 1095 patients were screened using a next generation sequencing panel. Further patients were ascertained from a network of epilepsy genetics clinics. Patients with severe DEE and BFIS were excluded from the study. Results: We found 36 probands who presented with an SCN8A-related epilepsy and normal intellect (33%) or mild (61%) to moderate ID (6%). All patients presented with epilepsy between age 1.5 months and 7 years (mean = 13.6 months), and 58% of these became seizure-free, two-thirds on monotherapy. Neurological disturbances included ataxia (28%) and hypotonia (19%) as the most prominent features. Interictal electroencephalogram was normal in 41%. Several recurrent variants were observed, including Ile763Val, Val891Met, Gly1475Arg, Gly1483Lys, Phe1588Leu, Arg1617Gln, Ala1650Val/Thr, Arg1872Gln, and Asn1877Ser. Significance: With this study, we explore the electroclinical features of an intermediate SCN8A-related epilepsy with mild cognitive impairment, which is for the majority a treatable epilepsy.
KW - SCN8A
KW - epilepsy
KW - epilepsy genetics
KW - intellectual disability
KW - voltage-gated sodium channels
UR - http://www.scopus.com/inward/record.url?scp=85064156848&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85064156848&partnerID=8YFLogxK
U2 - 10.1111/epi.14705
DO - 10.1111/epi.14705
M3 - Article
C2 - 30968951
AN - SCOPUS:85064156848
SN - 0013-9580
VL - 60
SP - 830
EP - 844
JO - Epilepsia
JF - Epilepsia
IS - 5
ER -